Advanced XFI by axiom insights: Imaging Without Limits. Imagine That.

Cut your preclinical R&D costs, reduce risk, and accelerate discovery with high-resolution, whole-body tracking for pharma and bio-technology.
3

The Challenge

Preclinical Research is Complex, Expensive, and Slow? Time to Change That!

Preclinical drug development faces bottlenecks in measuring and understanding drugs inside the body. Accurate tracking is difficult. Traditional methods sacrifice animals at each time point, and relying on imaging such as PET/SPECT provides only limited insights. Most approaches can track only a single drug at a time. The result: costly, slow, and incomplete studies with a high risk of failure. Advanced XFI delivers true quantitative measurements, achieving approximately ±20% accuracy. This is a significant breakthrough compared to conventional imaging technologies.

Advanced XFI by axiom insights: an Imaging Revolution.

axiom insights applies a groundbreaking imaging method that overcomes these limits. With X-Ray Fluorescence Imaging (XFI), you can track drugs, nanoparticles, and immune cells directly in vivo, across the entire body, over time, and without depth restrictions. For the first time, you see exactly how many entities are present and where. Even better: you can track multiple types at once — for example, your own drug candidate and a competitor’s compound in the same animal. This gives you unprecedented insights into immune response dynamics and drug efficacy, faster and with far greater precision.

Benefits of advanced XFI
by axiom insights

Ready to See the Unseen?

axiom’s advanced XFI is a game-changer for preclinical research: It allows you to track drugs, carriers, and immune cells with unmatched precision — non-invasively across the whole body, and over time. This means faster insights, stronger data, fewer test animals, and lower costs.

“Advanced XFI by axiom insights offers a faster, simpler, and more accurate way to gain multi-tracking insights into pharmacokinetics and cell tracking.”

Prof. Dr. Florian Grüner, Co-Founder

See the Future of
Preclinical Insight.

With advanced XFI by axiom insights, you generate clearer data in less time, make faster decisions, and reduce both animal use and study costs. You also strengthen your regulatory submissions and can bring new therapies to market faster. In short, you gain higher quality, lower risk, and a lasting competitive advantage. Ready to see the future?

Services

Full Service For
a Full Picture.

axiom insights offers you more than a revolutionary imaging method: Our all-in-one service package has been designed to make Advanced XFI work for your specific case. From expert consulting and study design to onboarding, training, and integration into your workflows, axiom insights ensures smooth adoption. We customize every project to your needs—with Deep Imaging and clear insights.

Investing: Can You Imagine the Possibilities?

Advanced XFI is not just a scientific breakthrough: It is a method with the potential to transform a multi-billion euro market. With access to world-class synchrotron infrastructure and researchers, as well as high entry barriers for competitors, axiom insights is a unique opportunity. Partner with us as we set out to define a new global imaging standard.

Better Insights are Possible. Time to Deliver Them.

Easy to adopt, easy to benefit from: With XFI by axiom insights, your studies run faster, cost less, and deliver higher-quality data while reducing animal use and supporting FDA/EMA compliance. Start small with a pilot project, validate your results, and scale easily with our full onboarding and training support.

“Years of development, combined with access to world-class research infrastructure at DESY, have enabled us to build a truly unique and powerful method.”

Prof. Dr. Florian Grüner, Co-Founder

Our Vision

A Game-Changing AI System Trained On The Best Data Ever.

XFI is only the beginning. As we establish the infrastructure and generate large-scale, high-quality datasets, we will build an AI-driven system that could radically accelerate drug development. This goes far beyond imaging: by training AI on rich biodistribution and efficacy data, we aim to predict how nanoparticles and drug candidates will behave before they are ever tested. Imagine rapidly narrowing down viable candidates, and improving entire workflows by orders of magnitude, while dramatically reducing the need for animal testing.

Your career at axiom insights

Working at axiom insights.

At axiom insights, you’ll help push the boundaries of science while shaping your own career. Join a world-class scientific environment with leading experts and state-of-the-art infrastructure, as you work across disciplines on a transformative technology. Enjoy the freedom to test, develop, and grow your ideas—supported by fair compensation and flexible hours. Join us in one of Europe’s most beautiful cities!

Frequently Asked Questions

Questions and Answers

Our answers to the questions around our XFI method. Yours is not among them? Feel free to reach out!

M
5

What is the main novelty of XFI by axiom insights method?

XFI by axiom insights delivers unmatched sensitivity and resolution, no depth limitations, and unlimited longitudinal tracking without radioactive tracers.
M
5

Why is XFI better than traditional imaging methods?

It provides clearer, deeper, and longer-term data at lower risk and cost, enabling insights not possible with other established methods.
M
5

How easily can we integrate XFI into our workflows?

Very easily. You start with a pilot project and scale the method according to your needs. Our experts support you on every step of the way.
M
5

What business value does XFI create for pharma?

XFI by axiom insights can help you shorten your R&D cycles, reduce costs and late-stage failure risk, and extend patent lifetimes for higher ROI.

It enables the collection of far more valuable data, for example through multi-tracking, while keeping handling much simpler because no radiochemistry is required.

M
5

Is the technology already proven?

Yes, it has been validated at DESY’s PETRA III synchrotron with reproducible, high-resolution results. See our proof of concept published in Scientific Reports (a Nature journal).

M
5

What partnerships are you looking for?

We seek partners to expand applications and proof-of-concept studies, and investors to scale, optimize, and build an AI-powered database to accelerate drug development even further.

M
5

How does XFI improve decision-making in drug development?

It could lead to more accurate go/no-go decisions and reduce unnecessary spending on weak candidates.

M
5

What infrastructure is required to use XFI?

No special hardware is needed. All measurements are performed on our unique setup at DESY Hamburg, where we provide full access, expertise, and integration support tailored to your specific needs.